PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.92%
Revenue growth under 50% of 3391.T's 18.76%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
5.52%
Gross profit growth under 50% of 3391.T's 17.55%. Michael Burry would be concerned about a severe competitive disadvantage.
29.29%
EBIT growth 1.25-1.5x 3391.T's 20.11%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
35.99%
Operating income growth above 1.5x 3391.T's 20.69%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
30.23%
Net income growth above 1.5x 3391.T's 13.28%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
30.21%
EPS growth above 1.5x 3391.T's 13.18%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
30.21%
Diluted EPS growth above 1.5x 3391.T's 13.10%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.27%
10Y revenue/share CAGR under 50% of 3391.T's 175.19%. Michael Burry would suspect a lasting competitive disadvantage.
-14.00%
Negative 5Y CAGR while 3391.T stands at 105.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
37.58%
3Y revenue/share CAGR at 50-75% of 3391.T's 58.04%. Martin Whitman would question if the firm lags behind competitor innovations.
100.00%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
204.55%
Net income/share CAGR at 50-75% of 3391.T's 343.10%. Martin Whitman might question if the firm’s product or cost base lags behind.
1.06%
Below 50% of 3391.T's 103.38%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
46.13%
3Y net income/share CAGR above 1.5x 3391.T's 14.36%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
174.00%
10Y equity/share CAGR in line with 3391.T's 169.69%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
20.89%
Below 50% of 3391.T's 79.92%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.68%
3Y equity/share CAGR above 1.5x 3391.T's 40.73%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.00%
Firm’s AR is declining while 3391.T shows 0.32%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.71%
Inventory shrinking or stable vs. 3391.T's 3.26%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.86%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.21%
BV/share growth above 1.5x 3391.T's 1.92%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
20.57%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-0.12%
We cut SG&A while 3391.T invests at 16.72%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.